Growth in this market is driven mainly by the increasing incidence of chronic diseases, government investments for cell-based research, the growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and growing GMP certifications for cell therapy production facilities.
The global cell expansion market in terms of revenue was estimated to be worth $14.9 billion in 2020 and is poised to reach $30.1 billion by 2025, growing at a CAGR of 15.1% from 2020 to 2025
